loading

Neonc Technologies Holdings Inc Aktie (NTHI) Neueste Nachrichten

pulisher
Apr 01, 2025

Neonc Technologies appoints new accounting firm By Investing.com - Investing.com Canada

Apr 01, 2025
pulisher
Apr 01, 2025

Neonc Technologies appoints new accounting firm - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

NeOnc Technologies Partners with CBCC for Clinical Expansion - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

NeOnc Technologies receives RPDD for NEO100 - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

NeOnc Technologies Holdings: New IPO gets a Rare Pediatric Disease Designation and a 37.92% Jump in the Market - RagingBull

Mar 31, 2025
pulisher
Mar 31, 2025

NeOnc Technologies Holdings' Perillyl Alcohol Receives FDA's Rare Pediatric Disease Designation - MarketScreener

Mar 31, 2025
pulisher
Mar 31, 2025

NeOnc Falls Despite FDA Nod - Baystreet.ca

Mar 31, 2025
pulisher
Mar 31, 2025

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Robinhood, Couchbase And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Mar 31, 2025
pulisher
Mar 31, 2025

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas - Yahoo Finance

Mar 31, 2025
pulisher
Mar 27, 2025

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments - The Manila Times

Mar 27, 2025
pulisher
Mar 27, 2025

NeOnc Technologies Expands Global Clinical Trial Network - GlobeNewswire

Mar 27, 2025
pulisher
Mar 26, 2025

NeOnc Technologies Holdings, Inc. Rings the Opening Bell - Nasdaq

Mar 26, 2025
pulisher
Mar 25, 2025

NTHI IPO NewsBiotech NeOnc Technologies' share registration declared effective ahead of Nasdaq direct listing - renaissancecapital.com

Mar 25, 2025
pulisher
Mar 25, 2025

NeOnc Technologies Holdings Announces Effectiveness of - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

NeOnc Technologies Holdings Announces Effectiveness of Registration Statement and Anticipated Listing Date of Common Stock on Nasdaq Global Market - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

NEONC Technologies Holdings, Inc. Appoints Dr. Alan Chiang to its Board of Directors - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

NeOnc Technologies Holdings, Inc. Appoints Bader Almonawer to Board of Directors - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

NeOnc Technologies Holdings, Inc. Appoints Dr. Steven L. Giannotta to Board of Directors - Nasdaq

Mar 25, 2025
pulisher
Mar 24, 2025

Nasdaq’s opening bell will ring for USC research startup NeOnc - USC Today

Mar 24, 2025
pulisher
Mar 12, 2025

Planet TV Studios Airing “New Frontiers” Episode on NeOnc Technologies Holdings, Inc. – Saturday, March 15, - EIN News

Mar 12, 2025
pulisher
Feb 19, 2025

Expanding horizons: NeOnc Technologies’ bold vision - The Business Journals

Feb 19, 2025
pulisher
Jan 07, 2025

NeOnc Technologies plans to go public through direct listing - AlphaStreet

Jan 07, 2025
pulisher
Jan 06, 2025

NeOnc Technologies has another go at a Nasdaq listing - Pharmaphorum

Jan 06, 2025
pulisher
Jan 03, 2025

Cancer Drug Co. Revives Bid To Go Public Via Direct Listing - Law360

Jan 03, 2025
pulisher
Oct 07, 2024

NeOnc Technologies Receives Pharma Tech Outlook’s Top Drug Delivery Platform Award for 2024 - GlobeNewswire

Oct 07, 2024
pulisher
Sep 08, 2024

A Biotech Going Through the Nose to Treat the Brain Plots Alternative Path to Public Markets - MedCity News

Sep 08, 2024
pulisher
Aug 05, 2024

NeOnc Technologies Begins Enrollment for Phase 2 Clinical - GlobeNewswire

Aug 05, 2024
pulisher
Jul 25, 2024

NeOnc Initiates Cohort 3 in Phase 1 Clinical Trial of NEO212™, a Patented Novel Hybrid Drug Designed to Deliver ‘Double Punch’ Against Malignant Brain Tumors - BioSpace

Jul 25, 2024
pulisher
Jul 16, 2024

NeOnc Technologies Receives FDA Approval to Expand - GlobeNewswire

Jul 16, 2024
pulisher
Jun 26, 2024

NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced Method of Delivering Novel Therapeutics to the Brain Under FDA Fast-Track Status - GlobeNewswire

Jun 26, 2024
pulisher
Dec 18, 2023

NeOnc Technologies Holdings: NTHI IPO, Health CarePhase 2 biotech developing intranasal and oral therapies for brain cancer. - renaissancecapital.com

Dec 18, 2023
pulisher
Jun 27, 2023

NeOnc Technologies Holdings Receives FDA Authorization to - GlobeNewswire

Jun 27, 2023
pulisher
Apr 18, 2023

NeOnc Technologies Appoints Sidra Medicine CEO and Forbes - GlobeNewswire

Apr 18, 2023
pulisher
Apr 04, 2023

NeOnc Technologies CEO, Thomas Chen, MD, Ph.D., Awarded American Health Council’s ‘Best in Medicine’ - GlobeNewswire

Apr 04, 2023
$60.29
price down icon 0.48%
$68.09
price down icon 1.58%
$17.32
price down icon 0.23%
$31.03
price down icon 0.26%
$86.82
price down icon 1.40%
biotechnology ONC
$220.54
price down icon 7.53%
Kapitalisierung:     |  Volumen (24h):